Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Blish

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|March 13, 2024
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutationsMichael Westberg, Yichi Su, Xinzhi Zou, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Elife|October 14, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics studyZicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Dissecting the epigenome dynamics in human immune cells upon viral and chemical exposure by multimodal single-cell profilingIrem B Gündüz, Bei Wei, Derek C Chen, et al.
Science Translational Medicine|January 25, 2023
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malariaMaureen Ty, Shenghuan Sun, Perri C Callaway, et al.
Nature Immunology|June 12, 2026
Human vaccine responses regulated by parallel cytokine pathwaysGuangbo Chen, Jing Guo, John Heath, et al.
Research Square|January 25, 2022
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infectionsAllan Feng, Emily Yang, Andrew Moore, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|March 13, 2024
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutationsMichael Westberg, Yichi Su, Xinzhi Zou, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Elife|October 14, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics studyZicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Dissecting the epigenome dynamics in human immune cells upon viral and chemical exposure by multimodal single-cell profilingIrem B Gündüz, Bei Wei, Derek C Chen, et al.
Science Translational Medicine|January 25, 2023
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malariaMaureen Ty, Shenghuan Sun, Perri C Callaway, et al.
Nature Immunology|June 12, 2026
Human vaccine responses regulated by parallel cytokine pathwaysGuangbo Chen, Jing Guo, John Heath, et al.
Research Square|January 25, 2022
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infectionsAllan Feng, Emily Yang, Andrew Moore, et al.
Pageof 2